Latest News and Press Releases
Want to stay updated on the latest news?
-
La Commission européenne commandera 1,25 million de doses de VLA2001, le vaccin à virus entier contre la COVID-19 de Valneva, en 2022 Saint-Herblain (France), le 20 juillet 2022 - Valneva SE (Nasdaq...
-
European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine
European Commission to order 1.25 million doses of Valneva’s whole-virus COVID-19 vaccine VLA2001 in 2022 Saint-Herblain (France), July 20, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
-
VALNEVA Déclaration d’actions et de droits de vote 30 juin 2022__________________________________________________________________________________________ Dénomination sociale : VALNEVAAdresse du...
-
VALNEVA Declaration of shares and voting rights June 30, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue...
-
VALNEVA Déclaration d’actions et de droits de vote Situation intermédiaire au 22 juin 2022__________________________________________________________________________________________ ...
-
VALNEVA Declaration of shares and voting rights Interim status at June 22, 2022__________________________________________________________________________________________ Company name:...
-
VLA2001 devient le premier vaccin contre la COVID-19 à recevoir une autorisation de mise sur le marché de type standard en Europe. Saint Herblain (France), 24 juin 2022 – Valneva SE (Nasdaq : VALN ;...
-
VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe Saint Herblain (France), June 24, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
-
Saint-Herblain (France), le 24 juin 2022 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que toutes les résolutions recommandées par le...
-
Valneva Announces Successful Outcome of its AGM and Appointment of two New Supervisory Board Members
Saint-Herblain (France), June 24, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were...